Fig. 1: Waterfall and Swimmer plot of responses and their durations.
From: Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
The waterfall plot shows responses for all patients who had response assessment (A n = 7). One patient on subprotocol G (ROS1) is not included as treatment was discontinued during cycle one for toxicity and response was not evaluable. The Swimmer plot shows the duration of responses for all patients (B n = 8). CR complete responses, PD progressive disease, PR partial response.
